These neuroendocrine adjustments re-establish a balanced LH/FSH ratio, attenuate ovarian androgen synthesis, and ultimately improve menstrual regularity and ovarian function in PCOS patients (36). Here, PLOD1 is linked to polycystic ovary syndrome.